Home»2017»1.8 Bimeda: Altresyn® (altrenogest) Rebranded OvaMedTM Following Product Acquisition from Ceva Animal Health

1.8 Bimeda: Altresyn® (altrenogest) Rebranded OvaMedTM Following Product Acquisition from Ceva Animal Health

0
Shares
Pinterest Google+

Oakbrook Terrace, Ill.; March 1st, 2017 – Bimeda Inc. is pleased to announce the renaming of its altrenogest product for horses.

The product, formerly marketed as Altresyn® was recently acquired from Ceva Animal Health as part of Bimeda’s strategic expansion into the equine segment.

“The trade name OvaMedTM more closely aligns with Bimeda’s brand identity and is a key step in the integration of the recently-acquired equine products within our portfolio and global brand” said Emmanuelle Lemaire-Galliot, Marketing Manager for Bimeda North America.

OvaMedTM is currently shipping to Bimeda’s distributors to fulfill veterinary orders. For more information, visit www.bimedaus.com and www.bimedaequine.com

Previous post

1.7 Bayer: Court Upholds Patent Infringement Suit Against Dow, Bayer to Receive $455 Million

Next post

1.9 Blue Buffalo CEO Forecast Internet Pet Food Sales Growth

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *

RETURN TO TABLE OF CONTENTS